Altimmune (ALT) Current Deferred Revenue (2011 - 2018)
Altimmune (ALT) posted quarterly Current Deferred Revenue of $173952.0 for Q3 2018, up 780.64% year-over-year from $19753.0 in Q3 2017, and up 0.89% quarter-over-quarter from $172414.0 in Q2 2018.
Powered by 
Analysis
Altimmune (ALT) Current Deferred Revenue (2011 - 2018) Analysis & Trends
Altimmune (ALT) has reported Current Deferred Revenue for 7 consecutive years, with $173952.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Current Deferred Revenue rose 780.64% year-over-year to $173952.0; the TTM figure through Sep 2018 stood at $173952.0 (up 780.64% YoY), while the FY2017 annual figure was $15914.0, down 19.44% from the prior year.
- Current Deferred Revenue rose to $173952.0 in Q3 2018 per ALT's latest filing, from $172414.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $173952.0 in Q3 2018 and bottomed at $15914.0 in Q4 2017.
- Historically, Current Deferred Revenue has averaged $67631.6 across 4 years, with a median of $38503.0 in 2017.
- Annual changes were most pronounced in 2014 — Current Deferred Revenue slumped 92.88% — and 2018, when it jumped 780.64%.
- Altimmune's Current Deferred Revenue stood at $62261.0 in 2014, then sank by 68.27% to $19753.0 in 2016, then dropped by 19.44% to $15914.0 in 2017, then soared by 993.08% to $173952.0 in 2018.
- Business Quant data shows ALT's Current Deferred Revenue at $173952.0 in Q3 2018, $172414.0 in Q2 2018, and $44753.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Altimmune | 636.07 Mn | 636.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 173,952.00 |
| Jun 30, 2018 | 172,414.00 |
| Mar 31, 2018 | 44,753.00 |
| Dec 31, 2017 | 19,753.00 |
| Sep 30, 2017 | 19,753.00 |
| Jun 30, 2017 | 32,253.00 |
| Dec 31, 2016 | 19,753.00 |
| Mar 31, 2014 | 62,261.00 |
| Dec 31, 2013 | 341,723.00 |
| Sep 30, 2013 | 471,816.00 |
| Jun 30, 2013 | 508,175.00 |
| Mar 31, 2013 | 874,404.00 |
| Dec 31, 2012 | 1.38 Mn |
| Dec 31, 2011 | 514,312.00 |